News

AddToAny

Google+ Facebook Twitter Twitter

Improving drug delivery

A group of US scientists has developed a new way to deliver molecules that target specific genes within cells.

Their platform, which uses a modified form of diphtheria toxin, has been shown to down-regulate critical genes in cancer cells, and could be used for other genetic diseases as well.

The team, led by professors Molly Shoichet and Roman Melnyk of SickKids Hospital, found inspiration from an unexpected source – diphtheria toxin.

Shoichet, said: “A major challenge in the field of drug delivery is most therapeutic vehicles cannot escape the acid environment of the endosome once they get into the cell.

“The diphtheria toxin platform as a delivery vehicle effectively solves that.”

The researchers used the system to deliver molecules that they believed would be effective against glioblastoma.  

bit.ly/3cBAr2e

 

Picture Credit | iStock

Related Articles

Under the microscope: The G protein-coupled estrogen receptor

Tell me about this receptor
The G protein-coupled estrogen receptor (let’s call it the GPER) is a seven-transmembrane-domain receptor that mediates non-genomic estrogen-related signalling.

Map of mutations

Research from UCL has identified almost 200 changes to the COVID-19 genome, each one a clue to revealing the history of the virus and possibly its future.

More effective stem cell transplant

Scientists have developed a new way to make blood stem cells present in the umbilical cord “more transplantable”.

Curative treatment for heart disease

Researchers trying to turn off a gene that allows cancers to spread have made a surprising U-turn.

Top